Information Provided By:
Fly News Breaks for April 10, 2018
TRHC
Apr 10, 2018 | 05:42 EDT
First Analysis analyst Frank Sparacino remains bullish on shares of Tabula Rasa HealthCare after hosting investor meetings with the company's CFO Brian Adams. The analyst reiterates an Overweight rating on the shares with a $47 price target. Tabula Rasa has a "unique" competitive position and a favorable secular backdrop with medication management and pharmacists playing a more integral role in value-based care, Sparacino tells investors in a research note. He sees the potential for 2018 revenue outperformance and thinks the company's organic revenue growth can exceed 20%. The analyst calls the latter a "rarity in the broader healthcare IT landscape today."
News For TRHC From the Last 2 Days
There are no results for your query TRHC